Historique
Bulletin de Périodique
Drug Testing and Analysis , Vol.10, n°5 - May 2018
Paru le :
01/05/2018
Année
2018
Page(s) :
797-909
Langue(s) :
Anglais
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Note de contenu :
SELECTION :
- Analysis of new psychoactive substances in oral fluids by means of microextraction by packed sorbent followed by ultra-high-performance liquid chromatography-tandem mass spectrometry. Rocchi R., Simeoni M.C., Montesano C., Vannutelli G., Curini R., Sergi M., et al., p. 865-873.
- Drug residues in used syringes in Switzerland: A comparative study. Lefrançois E., Augsburger M., Esseiva P., p. 874-879.
- Phase I metabolism of the recently emerged synthetic cannabinoid CUMYL-PEGACLONE and detection in human urine samples. Mogler L., Wilde M., Huppertz L.M., Weinfurtner G., Franz F., Auwärter V., p. 886-891.
- Identification of oxymorphone as decomposition product of the permitted drug methylnaltrexone. Sobolevsky T., Kucherova Y., Ahrens B., p. 892-895.
- The importance of biomarkers of fetal exposure to alcohol and psychotropic drugs in early diagnosis: A case report. Jarque P., Marchei E., Roca A., Gomila I., Pichini S., Busardo F.P., et al., p. 895-898.
- Another chemically masked drug: p-tosyl methylamphetamine. Collins M., Bhattarai A., Salouros H., p. 898-905.
- Analysis of new psychoactive substances in oral fluids by means of microextraction by packed sorbent followed by ultra-high-performance liquid chromatography-tandem mass spectrometry. Rocchi R., Simeoni M.C., Montesano C., Vannutelli G., Curini R., Sergi M., et al., p. 865-873.
- Drug residues in used syringes in Switzerland: A comparative study. Lefrançois E., Augsburger M., Esseiva P., p. 874-879.
- Phase I metabolism of the recently emerged synthetic cannabinoid CUMYL-PEGACLONE and detection in human urine samples. Mogler L., Wilde M., Huppertz L.M., Weinfurtner G., Franz F., Auwärter V., p. 886-891.
- Identification of oxymorphone as decomposition product of the permitted drug methylnaltrexone. Sobolevsky T., Kucherova Y., Ahrens B., p. 892-895.
- The importance of biomarkers of fetal exposure to alcohol and psychotropic drugs in early diagnosis: A case report. Jarque P., Marchei E., Roca A., Gomila I., Pichini S., Busardo F.P., et al., p. 895-898.
- Another chemically masked drug: p-tosyl methylamphetamine. Collins M., Bhattarai A., Salouros H., p. 898-905.
Cote :
Abonnement
Dépouillements
Ajouter le résultat à votre sélection
E. LEFRANÇOIS ;
M. AUGSBURGER ;
P. ESSEIVA
|
2018
Dans Drug Testing and Analysis (Vol.10, n°5, May 2018) Article : Périodique
Dans Drug Testing and Analysis (Vol.10, n°5, May 2018) Article : Périodique
Harm reduction services, including needle-exchange programmes, have been implemented in Switzerland for over 20years. Their main aim is to lessen the negative social and/or physical consequences associated with illicit drug consumption and, ther[...]